Filing Details
- Accession Number:
- 0001562180-17-002102
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-31 16:58:39
- Reporting Period:
- 2017-05-26
- Filing Date:
- 2017-05-31
- Accepted Time:
- 2017-05-31 16:58:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
842023 | Bio-Techne Corp | TECH | Biological Products, (No Disgnostic Substances) (2836) | 411427402 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1344987 | A Charles Dinarello | 333 15Th Street Boulder CO 80302 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-05-26 | 5,000 | $66.59 | 12,473 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-05-31 | 5,000 | $111.37 | 7,473 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to buy) | Disposition | 2017-05-26 | 5,000 | $0.00 | 5,000 | $66.59 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2007-10-25 | 2017-10-24 | No | 4 | M | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | $91.78 | 2014-10-30 | 2024-10-30 | 4,000 | 4,000 | Direct |
Common Stock | Stock Option (right to buy) | $87.39 | 2013-10-31 | 2023-10-30 | 4,000 | 4,000 | Direct |
Common Stock | Stock Option (right to buy) | $87.34 | 2015-10-29 | 2025-10-28 | 4,260 | 4,260 | Direct |
Common Stock | Stock Option (right to buy) | $70.35 | 2011-10-27 | 2021-10-26 | 5,000 | 5,000 | Direct |
Commons Tock | Stock Option (right to buy) | $66.90 | 2012-10-25 | 2022-10-24 | 5,000 | 5,000 | Direct |
Common Stock | Stock Option (right to buy) | $65.47 | 2008-10-23 | 2018-10-22 | 5,000 | 5,000 | Direct |
Common Stock | Stock Option (right to buy) | $63.03 | 2009-10-29 | 2019-10-28 | 5,000 | 5,000 | Direct |
Common Stock | Stock Option (right to buy) | $61.46 | 2010-10-28 | 2020-10-27 | 5,000 | 5,000 | Direct |
Common Stock | Stock Options (Right to buy) | $101.19 | 2026-10-26 | 3,985 | 3,985 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2024-10-30 | 4,000 | 4,000 | Direct |
2023-10-30 | 4,000 | 4,000 | Direct |
2025-10-28 | 4,260 | 4,260 | Direct |
2021-10-26 | 5,000 | 5,000 | Direct |
2022-10-24 | 5,000 | 5,000 | Direct |
2018-10-22 | 5,000 | 5,000 | Direct |
2019-10-28 | 5,000 | 5,000 | Direct |
2020-10-27 | 5,000 | 5,000 | Direct |
2026-10-26 | 3,985 | 3,985 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.3699 to $111.3790, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The option vests on the earlier of the one year anniversary of the grant date (10/27/2017) or the date of Bio-Techne 2017 annual meeting of shareholders.